ArrowMark Colorado Holdings’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$45.1M Sell
866,841
-496,598
-36% -$25.8M 0.81% 40
2025
Q1
$87M Sell
1,363,439
-147,072
-10% -$9.38M 1.41% 17
2024
Q4
$72.2M Sell
1,510,511
-500,144
-25% -$23.9M 0.97% 32
2024
Q3
$115M Sell
2,010,655
-80,046
-4% -$4.58M 1.47% 17
2024
Q2
$109M Buy
2,090,701
+231,860
+12% +$12.1M 1.31% 19
2024
Q1
$75.6M Buy
1,858,841
+282,758
+18% +$11.5M 0.85% 37
2023
Q4
$58.3M Buy
1,576,083
+48,370
+3% +$1.79M 0.64% 53
2023
Q3
$58.4M Buy
1,527,713
+205,473
+16% +$7.85M 0.71% 46
2023
Q2
$47.7M Buy
1,322,240
+165,642
+14% +$5.97M 0.52% 61
2023
Q1
$44.2M Buy
+1,156,598
New +$44.2M 0.5% 59
2014
Q3
Sell
-20,000
Closed -$198K 295
2014
Q2
$198K Sell
20,000
-15,076
-43% -$149K 0.01% 280
2014
Q1
$446K Buy
35,076
+4,076
+13% +$51.8K 0.01% 233
2013
Q4
$465K Buy
31,000
+14,237
+85% +$214K 0.01% 228
2013
Q3
$185K Buy
+16,763
New +$185K 0.01% 244